ICH E6 (R2):
Best Practice Implementation and Technology Solutions for Pending Updates to Global GCP Guidelines
About this webinar
With the impending finalization of the ICH E6 R2 Addendum, sponsors are taking the necessary actions to incorporate best-in-class tools and processes to meet the enhanced guidelines around data transparency and risk-based methodologies. Comprehend has partnered with Chaucer Life Sciences to blend its technology solutions for CRO oversight and Risk Based monitoring initiatives, with Chaucer’s expertise within clinical operations, GCP quality and vendor management.
During this webinar, Comprehend and Chaucer will discuss how to prepare your organization for excellence related to the increased requirements in vendor management, operational data collection and reporting, and risk-based monitoring. We will also provide a demonstration of the following:
- Comprehend’s Best Practice KPIs, analytics and collaboration across systems, studies and CRO’s
- Chaucer’s Vendor Engagement and Oversight (VEO) framework
- Chaucer’s Risk Management tools
Who should attend
- Clinical Trial/Clinical Study Management
- Clinical Data/Informatics/IT
- Clinical Outsourcing
- Protein/Antibody Engineering
- Biometrics/Biostatistics
- Business Technology/Applications/Solutions
- Business Analyst
- CTO
- Project Management
Featured Speakers
Julie Peacock
Closely aligned with customers and the sales organization, Julie focuses on enabling prospects and customers on Comprehend’s Clinical Intelligence solutions. She manages go to market strategy, sales enablement, and product marketing.
Prior to Comprehend, Julie spent 18 years at Oracle Corporation in the enterprise application space where she managed strategy, field enablement and launch activities for a series of BtoB solutions. Julie holds a bachelor’s degree in Marketing from Auburn University.
Chris Panteli
Chris Panteli has led multiple programs to strengthen vendor management and risk based approaches within Pharmaceutical sponsor organizations. Chris also benefits from consulting in other industries such as Oil & Gas as well as working within industry in Pharmaceuticals and brings years of experience in running large programs and integrating technology and advancement in delivering innovative approaches. In addition to providing solutions for Chaucer’s clients, Chris is a key member of Chaucer’s solution development team across brands.
Partners for this event
Comprehend
Comprehend offers a suite of Clinical Intelligence applications that enables ClinOps Execs, Data Managers and Medical Monitors to significantly improve the speed, safety and quality of a portfolio of clinical trials. Across studies, sites, systems and CROs, Comprehend’s Clinical Intelligence Suite is particularly effective for centralized monitoring, risk monitoring, CRO oversight and collaboration, and medical monitoring initiatives. Comprehend gives life sciences companies a new source of competitiveness and the confidence to deliver high quality trial submissions at a new speed. Comprehend: the speed to quality results. Learn more at www.comprehend.com
Chaucer Life Sciences
Chaucer Life Sciences has been supporting the life sciences sector as specialists for 30 years.
In this continuously changing industry, we understand the challenges that our clients face first-hand, as well as the opportunities for driving high impact change. We employ experienced consultants working from hubs in Europe and the US who work side-by-side with our clients to deliver results-driven programs across the drug continuum and corporate functions.
Related webinars
More from Comprehend.
Meet your RBM Initiatives with Event-Driven Analytics
Collaborative Risk Management: Plan & Pivot Your Clinical Studies
Implementing ICH E6(R2): Getting the Balance Right
Best Practices in Defining and Aggregating Study Data for Oversight
New Tufts Study: Assessing CRO Oversight Effectiveness and Impact
Three Key Ways ICH E6(R2) Impacts Study Oversight
Critical CRO Oversight Metrics: How to Establish the Right Metrics and Monitor them in Real-time
How One Clinical Operations Team Returned 100% of Studies to Within Risk Threshold: A Next Gen Monitoring Case Study
Next Generation Centralized and Risk Monitoring
3 Adjustments Every Clinical Operations Executive Needs to Make to Increase Clinical Site Productivity
ICH E6(R2) Benchmark Survey: Essential Elements of Compliant CRO Oversight